Asia-Pacific Expansion Recent strategic collaboration with Karis Bio Inc. provides an opportunity for expansion into the Asia-Pacific region, tapping into a growing market for personalized regenerative therapies.
Financial Boost Significant funding from ARPA-H and other venture capital firms totaling $112 million presents a substantial financial backing for scaling operations and innovation in biomanufacturing technologies.
Cutting-Edge Therapy Development of Nebula-powered Autologous iPSC therapy for cardiovascular disease in partnership with Karis Bio positions Cellino at the forefront of cutting-edge regenerative treatments, offering a unique selling point in the market.
Expert Leadership Appointment of industry expert Chris Gibson as a member of the Board of Directors enhances Cellino's credibility and industry connections, potentially opening doors for strategic partnerships and collaborations.
Personalized Medicine Demand Growing focus on personalized treatments derived from iPSCs aligns with market trends towards personalized medicine, presenting Cellino with a strong sales opportunity in addressing chronic degenerative diseases.
$50M$100M
$100M$1B
$100M$1B
$1B
$10M$50M
$100M$1B
$10M$50MCellino uses 8 technology products and services including RSS, MySQL, Webpack, and more. Explore Cellino's tech stack below.
| Cellino Email Formats | Percentage |
| FLast@cellinobio.com | 50% |
| FLast@cellinobio.com | 50% |
Biotechnology ResearchUnited States51-200 Employees
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell and tissue replacement therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.
Company Overview
Media & News
Funding & FinancialsCellino has raised a total of $112M of funding over 3 rounds. Their latest funding round was raised on Jan 25, 2022 in the amount of $80Mas a Series A.
Cellino's revenue is in the range of $10M$50M
Funding & FinancialsCellino has raised a total of $112M of funding over 3 rounds. Their latest funding round was raised on Jan 25, 2022 in the amount of $80Mas a Series A.
Cellino's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com